Skip to main content

Dicyclomine Oral Presentations Shortage

Last Updated: March 10, 2024
Status: Current

Products Affected - Description
    • Dicyclomine hydrochloride capsule, Hikma, 10 mg, bottle, 100 count, NDC 00054-0748-25
    • Dicyclomine hydrochloride capsule, Hikma, 10 mg, bottle, 1000 count, NDC 00054-0748-31
    • Dicyclomine hydrochloride solution, Hikma, 10 mg/5 mL, 473 mL bottle, NDC 00054-0622-63
    • Dicyclomine hydrochloride tablet, Hikma, 20 mg, bottle, 100 count, NDC 00143-1227-01
    • Dicyclomine hydrochloride tablet, Hikma, 20 mg, bottle, 1000 count, NDC 00143-1227-10
    • Dicyclomine hydrochloride capsule, Mylan (Viatris), 10 mg, bottle, 100 count, NDC 00378-1610-01 - discontinued
    • Dicyclomine hydrochloride capsule, Mylan (Viatris), 10 mg, bottle, 500 count, NDC 00378-1610-05 - discontinued
    • Dicyclomine hydrochloride tablet, Mylan (Viatris), 20 mg, bottle, 100 count, NDC 00378-1620-01 - discontinued
    • Dicyclomine hydrochloride tablet, Mylan (Viatris), 20 mg, bottle, 500 count, NDC 00378-1620-05 - discontinued
Reason for the Shortage
    • Hikma did not provide a reason for the shortage.
    • Lannett has dicyclomine capsules and tablets available.
    • Mylan discontinued the 20 mg tablets in June 2021. The 10 mg tablet presentations were discontinued in 2022.
    • Par Pharmaceuticals has dicyclomine oral solution available.
    • Teva did not provide a reason for the shortage.
Available Products
    • Dicyclomine hydrochloride capsule, Lannett, 10 mg, bottle, 100 count, NDC 00527-0586-01
    • Dicyclomine hydrochloride capsule, Lannett, 10 mg, bottle, 1000 count, NDC 00527-0586-10
    • Dicyclomine hydrochloride tablet, Lannett, 20 mg, bottle, 100 count, NDC 00527-1282-01
    • Dicyclomine hydrochloride tablet, Lannett, 20 mg, bottle, 1000 count, NDC 00527-1282-10
    • Dicyclomine hydrochloride solution, Par Pharmaceuticals, 10 mg/5 mL, 473 mL bottle, NDC 00603-1161-58
    • Dicyclomine hydrochloride capsule, Teva, 10 mg, bottle, 100 count, NDC 00591-0794-01
    • Dicyclomine hydrochloride capsule, Teva, 10 mg, bottle, 1000 count, NDC 00591-0794-10
    • Dicyclomine hydrochloride tablet, Teva, 20 mg, bottle, 100 count, NDC 00591-0795-01
    • Dicyclomine hydrochloride tablet, Teva, 20 mg, bottle, 1000 count, NDC 00591-0795-10

Estimated Resupply Dates

    • Hikma has all presentations on allocation.

Updated

Updated March 10, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created January 22, 2019 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer